About

Winner of the 2024 NOME Annual Meeting Startup Competition.

52North on the market with low-cost, market-pull-driven clinical decision support tools, creating rapid, low-cost, portable, scalable, and accessible devices to get critical data earlier – with the first application being a point-of-care rapid test to triage cancer patients at risk of neutropenic sepsis.